ストックスクリーナーアプリを入手
34.57
3.92%
-1.40
前日終値:
$35.97
開ける：
$35.91
24時間の取引高:
1.28M
Relative Volume:
0.32
時価総額：
$3.76B
収益：
-
当期純損益:
$-95.90M
株価収益率:
-26.19
EPS:
-1.32
ネットキャッシュフロー:
$-79.09M
1週間 パフォーマンス:
-5.57%
1か月 パフォーマンス:
-16.78%
6か月 パフォーマンス:
+467.49%
1年 パフォーマンス:
+644.83%
1日の値動き範囲:
$34.55
$36.46
1週間の範囲:
$34.55
$37.93
52週間の値動き範囲:
$1.865
$48.26
Terns Pharmaceuticals Inc Stock (TERN) Company Profile
名前
Terns Pharmaceuticals Inc
セクター
電話
650-525-5535 EXT.101
住所
1065 EAST HILLSDALE BLVD., SUITE 100, FOSTER CITY
TERN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TERN
Terns Pharmaceuticals Inc
|
34.55 | 3.91B | 0 | -95.90M | -79.09M | -1.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.56 | 118.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
751.87 | 79.40B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
816.00 | 51.18B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
362.87 | 48.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
339.26 | 37.49B | 4.98B | 69.59M | 525.67M | 0.5197 |
Terns Pharmaceuticals Inc Stock (TERN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-04 | アップグレード | H.C. Wainwright | Neutral → Buy |
| 2025-11-03 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2025-10-15 | 開始されました | Truist | Buy |
| 2025-09-17 | 開始されました | Barclays | Overweight |
| 2025-09-04 | 再開されました | H.C. Wainwright | Neutral |
| 2025-02-28 | 開始されました | William Blair | Mkt Perform |
| 2024-10-31 | 開始されました | Oppenheimer | Outperform |
| 2023-06-22 | 開始されました | Mizuho | Buy |
| 2023-06-07 | 開始されました | Jefferies | Buy |
| 2023-05-31 | 開始されました | ROTH MKM | Buy |
| 2023-05-08 | 開始されました | BMO Capital Markets | Outperform |
| 2023-02-14 | 開始されました | JMP Securities | Mkt Outperform |
| 2023-02-07 | 開始されました | UBS | Buy |
| 2022-09-12 | 開始されました | H.C. Wainwright | Neutral |
| 2021-09-14 | 再開されました | Goldman | Buy |
| 2021-03-02 | 開始されました | Cowen | Outperform |
| 2021-03-02 | 開始されました | Goldman | Buy |
| 2021-03-02 | 開始されました | JP Morgan | Overweight |
すべてを表示
Terns Pharmaceuticals Inc (TERN) 最新ニュース
Terns Pharmaceuticals Expands Global Rights to TERN-701 - TipRanks
Terns Pharmaceuticals amends license agreement with Hansoh for TERN-701 rights - Investing.com
What technical signals suggest for Terns Pharmaceuticals Inc. stockQuarterly Trade Summary & Low Risk Profit Maximizing Plans - bollywoodhelpline.com
Assessing Terns Pharmaceuticals (TERN) Valuation After New TERN-701 Data And Capital Raise - Sahm
Wall Street Forecasts 42.31% Upside To Terns Pharmaceuticals, Inc. (TERN) - Finviz
Wall Street forecasts 42.31% upside to Terns Pharmaceuticals, Inc. (TERN) - MSN
How Investors Are Reacting To Terns Pharmaceuticals (TERN) Promising TERN-701 Phase 1 CARDINAL Data - Sahm
Terns Pharmaceuticals stock jumps 10% as JPM conference puts TERN-701 back on the map - TechStock²
Terns Pharmaceuticals (NASDAQ:TERN) Trading Up 10.4%Should You Buy? - MarketBeat
Aug Patterns: Can Terns Pharmaceuticals Inc stock sustain institutional interestJuly 2025 Final Week & Consistent Profit Trade Alerts - Bộ Nội Vụ
J.P. Morgan: Terns Looks To Take Flight With TERN-701 In 2026 - Citeline News & Insights
William Blair reiterates Outperform rating on Terns Pharmaceuticals stock By Investing.com - Investing.com Canada
Terns Pharmaceuticals (TERN) Valuation After Encouraging TERN 701 CML Data And Capital Raise Powered Development Plans - Yahoo Finance
Citizens Maintains An Outperform Rating On Terns Pharmaceuticals, Inc. (TERN) - Insider Monkey
Terns Pharmaceuticals (NASDAQ:TERN) Trading Down 6.3%Here's Why - MarketBeat
Assessing Terns Pharmaceuticals (TERN) Valuation After Recent Share Price Swings And Elevated Price To Book Ratio - Sahm
Analysts Offer Insights on Healthcare Companies: Anteris Technologies Global Corp. (AVR) and Terns Pharmaceuticals (TERN) - The Globe and Mail
How Rhythm Pharmaceuticals, Inc. stock performs during market volatility - Улправда
Tern Pharmaceuticals (TERN) soars 630% on CML treatment best-in-class potential - MSN
Terns Pharmaceuticals (TERN) price target increased by 75.91% to 54.63 - MSN
Why Terns Pharmaceuticals Inc. stock could see breakout soonEarnings Beat & Consistent Return Investment Signals - ulpravda.ru
Why Terns Pharmaceuticals Inc. stock could be next big winnerEarnings Recap Summary & Daily Entry Point Trade Alerts - Улправда
Will Fast Track TERN-701 Status and $747.5 Million Raise Change Terns Pharmaceuticals' (TERN) Narrative - Sahm
Terns Pharmaceuticals to Highlight 2026 Priorities and Program Milestones at the 44th Annual J.P. Morgan Healthcare Conference - TradingView — Track All Markets
Star Tribune - FinancialContent
Terns Pharmaceuticals CMO Kuriakose sells $44,552 in stock By Investing.com - Investing.com Nigeria
Terns Pharmaceuticals CMO Kuriakose sells $44,552 in stock - Investing.com
Terns Pharmaceuticals CEO Burroughs sells $2.7m in shares By Investing.com - Investing.com South Africa
Terns Pharmaceuticals CEO Burroughs sells $2.7m in shares - Investing.com
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4) - The Manila Times
With 53% Institutional Ownership, Terns Pharmaceuticals, Inc. (NASDAQ:TERN) Is a Favorite Amongst the Big Guns - 富途牛牛
Terns Pharmaceuticals reports inducement grants to new employees under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Terns Pharmaceuticals Reports Inducement Grants To New Employees Under Nasdaq Listing Rule 5635(C)(4) - TradingView — Track All Markets
Tern Pharmaceuticals (TERN) Soars 630% on CML Treatment Best-in-Class Potential - Insider Monkey
Meet the 10 Market Stars Behind Millionaire-Making in 2025 - Insider Monkey
Terns Pharmaceuticals Earnings Notes - Trefis
The biggest end-of-year sale in the Bay Area was for $4 billion in biotech stockSan Francisco Business Times - The Business Journals
12 Overlooked Stocks That Delivered Massive Gains In 2025 - RTTNews
Terns Pharmaceuticals stock slides today, testing the $40 level after December share sale - ts2.tech
Exchange Traded Concepts LLC Has $912,000 Position in Terns Pharmaceuticals, Inc. $TERN - MarketBeat
Terns Pharmaceuticals stock soars after leukemia drug delivers big early responses in tough-to-treat patients - MSN
Pharmaceutical Stocks To Follow TodayDecember 10th - MarketBeat
Terns Pharmaceuticals proposes $400M equity offering - MSN
Terns Pharmaceuticals (TERN) climbs 53% on stellar leukemia treatment trial - MSN
Truist Securities maintains Terns Pharmaceuticals (TERN) buy recommendation - MSN
Terns Pharmaceuticals (TERN) Is Down 7.7% After Strong TERN-701 Phase 1 DataHas The Bull Case Changed? - Sahm
Jim Cramer highlights massive gains for Terns Pharmaceuticals shareholders - MSN
Terns Pharmaceuticals Inc (TERN) 財務データ
収益
当期純利益
現金流量
EPS
3.31%
2.06%
大文字化:
|
ボリューム (24 時間):